Background: Various conjugated cholesterol metabolites are excreted in urine of the patients with metabolic abnormalities and hepatobiliary diseases. We aimed to examine the usefulness of precursor ion scan and neutral loss scan for the characterization of conjugated cholesterol metabolites in urine. Methods: A mixture of authentic standards of conjugated cholesterol metabolites was used for investigating the performance of the present method. The urine of patients with Niemann-Pick diseases type C and 3b-hydroxysteroid dehydrogenase deficiency were analysed by precursor ion scan of m/z 97, 74, and 124. Results: A precursor ion scan of m/z 97 was effective for identifying conjugates with ester sulphates on hydroxyl groups whereas ester sulphates on phenolic alcohols were signalled by a neutral loss scan of 80 Da. Monosaccharide-conjugated cholesterol metabolites were signalled by a precursor ion scan of m/z 113. Although precursor ion scan of m/z 74 and 124 was effective for finding glycine-and taurine-conjugated metabolites, high intensity of product ions (m/z 74 and 124) disturbed measurement of other multiply conjugated metabolites. The urine samples contained many conjugated cholesterol metabolites, and there were several disease-specific intense peaks. We found several unknown intense peaks with three known peaks in urine of the Niemann-Pick type C patient. In the patient with 3b-hydroxysteroid dehydrogenase deficiency, intense peaks that were tentatively identified as 5-cholenoic acid sulphates and their glycine and taurine conjugates were present. Conclusion: The method should lead to the discovery of new urinary biomarkers for these disturbances of cholesterol catabolism and transport.
Introduction
Cholesterol is converted to bile acids, vitamin D, and steroid hormones. Although cholesterol and its esters are lipid-soluble substances, their metabolites are much more hydrophilic because of the addition of hydroxyl, carbonyl, and/or carboxyl groups. The hydroxyl and carboxyl groups may be in turn modified by 'conjugation' with amino acids such as glycine or taurine, 1 sulfuric acid, 2 glucuronic acid, 3 N-acetylglucosamine (GlcNAc), 4 glucose, 5 and galactose. 6 These conjugations have profound effects on the fate of such molecules. Conjugates may be less tightly bound to albumin, and therefore enter the glomerular filtrate, increasing renal excretion. In addition, if conjugates are accumulated in the hepatocyte because of inadequate canalicular transport into bile, they may regurgitate into plasma and be eliminated in urine. Thus, the presence of conjugates of cholesterol metabolites in urine could indicate inborn defects of cholesterol metabolism or transport and serve as biomarkers for these genetic diseases. Inborn defects of cholesterol metabolism include 3b-hydroxysteroid-Á 5 -C 27 -steroid dehydrogenase (3b-HSD) deficiency, 7,8 Á 4 -3-oxosteroid 5b-reductase deficiency, 9, 10 oxysterol 7a-hydroxylase deficiency, 11 and sterol 27-hydroxylase deficiency. 12 In patients of 3b-HSD deficiency, severe cholestasis, pruritus, jaundice, and cirrhosis appear as clinical symptoms. Giant cell change is shown as a pathological finding. 7 On the other hand, Niemann-Pick disease, type C (NPC), 13 is known as inborn defect of cholesterol transport, and patients are common in Europe, the United States, and Japan. In patients of NPC, intrahepatic cholestasis, splenohepatomegaly, and neurological and psychiatric symptoms appear, and accumulation of cholesterol, sloughing off of Purkinje cell, and swelling of axon appear as pathological features. 14 Liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) appears to be the best technique for analysis of urinary conjugated cholesterol metabolites. [15] [16] [17] [18] [19] If we have preliminary information on the nature of disease-specific molecules, we should be able to analyse target molecules with high sensitivity by using selected reaction monitoring mode. However, there are many unknown biomarker candidates including molecules for which synthetic reference standards are unavailable. Taguchi et al. reported that precursor ion scan and neutral loss scan were effective for focused analysis of lipids possessing common partial structures, 20 and the technique is reviewed by Griffiths and Sjo¨vall. 21 We have previously investigated the characteristics of fragmentation patterns obtained by low-energy collision-induced dissociation (CID) of various conjugated cholesterol metabolites. 22 According to conjugation types, characteristic product ions and/or neutral losses were observed in the product ion spectra. Thus, precursor ion scan and neutral loss scan have the potential to be effective for focused analysis of conjugated cholesterol metabolites.
In this study, we investigated the usefulness of precursor ion scan and neutral loss scan using characteristic fragment pattern of various conjugated cholesterol metabolites for focused analysis. We then applied the technique to the analysis of urine samples from a patient with NPC, a disease of cholesterol transport, and another with 3b-HSD deficiency, a genetic defect in bile acid biosynthesis, to validate the usefulness of the method.
Material and methods

Chemicals and materials
Cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), ursodeoxycholic acid (UDCA), and lithocholic acid (LCA) were purchased from Nakalai Tesque, Inc. (Kyoto, Japan). Glycine-and taurine-conjugated bile acids, 23 bile acid 3-sulphates, 24 bile acid 3-glucuronides, 25 bile acid 24-glucuronides, 26 bile acid 7b-GlcNAc conjugates, 27 bile acid 3-glucosides, 28 bile acid 24-galactosides, 29 3b-sulfooxy-7b-N-acetylglucosaminyl-5-cholen-24-oic acid (SNAG-Á 5 -CA), and its glycine (SNAG-Á 5 -CG) and taurine conjugates (SNAG-Á 5 -CT) were synthesized in our laboratories using previously reported methods. 30 All standard specimens were dissolved in water/ethanol (1:1, v/v) at a concentration of 100 mg/L as stock solutions. A mixture of all reference compounds was prepared, with a concentration of 2.0 mol/L for each compound. Ultrapure water was prepared using a PURELAB ultra apparatus (Organo Co., Ltd, Tokyo, Japan). All other chemicals were analytical grade and solvents were HPLC or LC/MS grade.
Urine from an NPC patient was collected at Tottori University Hospital. The patient is a male 3-monthold infant. The patient was receiving oral UDCA when the urine sample was collected. Urine from a patient with 3b-HSD deEciency (a male 6-month-old infant) and a normal infant (a female 3-month-old infant) were donated by the Junshin Clinic Bile Acid Institute (Tokyo). A healthy adult is a 21-year-old man. All experiments were carried out according to the protocol approved by the ethical committee of the Graduate School of Medicine in Tohoku University.
Focused analysis conditions for conjugated cholesterol metabolites
Mass spectrometric analysis was performed using an API 5000 mass spectrometer (AB Sciex Pte. Ltd, Framingham, MA, USA) equipped with an ESI probe. It was coupled with a Nanospace SI-2 LC system (Shiseido Co., Ltd, Tokyo). Ion spray voltage, declustering potential, and turbospray gas probe were set at -4500, -80 V, and 700 C, respectively. Curtain gas, ion source gas1, ion source gas2, and collision gas were nitrogen and their flow was set to 25, 40, 60, and 6 units, respectively. A 100 L of water and 100 L of standard solution (2.0 mol/L each) were mixed, and 50 L of aliquots were injected into the LC/ESI-MS/ MS system. Analytes were concentrated at the inlet edge of a trapping column (Shim-pack MAYI-C8, 4.6 mm i.d. Â 10 mm, Shimadzu, Corp., Kyoto) using a mixture of 20 mmol/L ammonium acetate solution (pH 7.0) and methanol (9:1, v/v) as a mobile phase for trapping at a flow rate of 1 mL/min. The six-port valve position was switched 3 min after and the analytes were separated on a YMC-Pack Pro C18 (5 m, 2.0 mm i.d.Â 250 mm, YMC, Co., Ltd, Kyoto) as an analytical column. Compounds were eluted by a linear gradient elution mode at a flow rate of 0.2 mL/min with the following condition: Solvent A, 20 mmol/L ammonium acetate solution (pH 7.0) and methanol (19:1, v/v); solvent B, (1:19, v/v); 50% solvent B was linearly changed to 80% solvent B against A over 120 min and then the rate of solvent B was kept at 80% for 20 min. The rate of solvent B was then switched to 50% and kept for 40 min. Collision voltages were set at -50, -60, -50, -80, and -55 V on precursor ion scans of m/z 74, 97, 113, 124, and m/z 202, respectively. Neutral loss scan of 80, 162, and 221 Da were set using a collision voltage of -50, -50, and -50 V, respectively. In analysis of GlcNAc conjugates, neutral loss spectra were measured at a scan range from m/z 230 to 900, and in other cases, precursor ion spectra and neutral loss spectra were measured at a scan range from m/z 200 to 900 with a scan time of 2 s. Accuracy of retention time and m/z were calculated as coefficient of variation (CV%). Inter-day accuracy of retention time was within 1.6% and intra-day accuracy was within 0.2%. Both interday and intra-day accuracy of m/z were within 0.03%. Data were collected and processed using Analyst 1.4.1 data collection and integration software.
Results and discussion
Focused approach for analysis of conjugated cholesterol metabolites First, we analysed a mixture of authentic conjugated cholesterol metabolites using the Q1-scan mode. Since we know retention times and m/z of all standard compounds, we can identify every peak by ion extraction (data not shown). Most authentic standards were found at the retention times from 8.55 to 126 min. However, C 27 compounds (cholesterol 3-sulphate, cholestanol 3-sulphate, epicoprostanol 3-sulphate, and cholesterol 3-glucuronide) were not eluted even at 140 min under the present analytical conditions. For more rapid elution of those compounds, more lipophilic mobile phases containing dichloromethane or chloroform are likely to be required. Figure 1 (a) is a total ion current (TIC) chromatogram using a precursor ion scan of m/z 74 for extraction of conjugated cholesterol metabolites possessing a glycine moiety. We were able to find 17 metabolites in the chromatogram and detect all metabolites possessing a glycine moiety, which we used as reference compounds in this study. The detected precursor ions included doubly charged deprotonated molecules because they have two acidic groups (carboxylic acid and sulfuric acid) in their molecules. In the TIC chromatogram using precursor ion scan of m/z 74, some pairs, such as peaks 8 and 9, peaks 10 and 11, and peaks 15 and 16, were not separated from each other; however, individual compounds can be distinguished by their m/z values. The TIC chromatogram in Figure 1 (b) is obtained using precursor ion scan of m/z 124. The peaks in this chromatogram were derived from all taurine-conjugated metabolites used as standards in this study. Although their chromatographic separations were incomplete, they were able to be distinguished by their m/z values as was the case with glycineconjugated metabolites.
Next, we performed precursor ion scan of m/z 97 for extraction of sulphate conjugates; the TIC chromatogram is shown in Figure 1 All tandem mass spectrometric and chromatographic conditions were as shown in 'Material and methods' section. The detected standard substances were numbered in each chromatograms. The peak list was shown in Table 1 . e.g. The peak 2 in chromatogram (a) corresponds to the peak No. A2, GUDCA 3-sulphate, and the peak 15 in chromatogram (b) corresponds to the peak No. B15, TLCA. on the phenolic hydroxyl group were found in the TIC chromatogram on neutral loss scan of 80 Da as shown in Figure 1(d) . Neutral loss of 80 Da was also able to extract amino acid-conjugated bile acid 3-sulphates in addition to estrogen C-3 sulphates. No non-amidated bile acid 3-sulphates were identified as precursors for the neutral loss of 80 Da, suggesting that somehow interaction between the side chain amino acid and the hydroxyl group at C-3 occurs. Thus, precursor ion scan of m/z 97 is effective for group-specific extraction of sulphate conjugates in which the sulphate group is linked by an ester bond to aliphatic alcohol substituents. On the other hand, neutral loss of 80 Da is effective for extraction of sulphate conjugates in which the sulphate is linked to a phenolic hydroxyl group although double conjugates with glycine or taurine can be found in the TIC chromatogram on neutral loss of 80 Da even in the case of sulphate conjugates linked to aliphatic alcohols. This fact is useful for identifying N-acyl amidates containing glycine or taurine. Figure 1 (e) shows a TIC chromatogram using the precursor ion scan of m/z 113. This product ion has been found in product ion spectra of monosaccharideconjugated compounds other than GlcNAc conjugates, although acyl galactosides exhibit relatively lower intense peaks on the TIC chromatogram. 22 According to our previous paper, a precursor ion scan of m/z 175 and neutral loss scan of 176 Da aids in the identification of the mode of conjugation of glucuronides, in ester linkage with the carboxyl group, in ether linkage with an aliphatic hydroxyl group, or a phenolic hydroxyl group. Thus, this approach will work well for discrimination of conjugation types of glucuronides possessing the same molecular masses. 22 Figure 1(f) shows the TIC chromatogram on neutral loss scan of 162 Da. Precursors include 15 different bile acid 3-glucosides. We were not able to find acyl galactosides because of their lower intensities. Peak intensities of amino acid conjugates are extremely lower than unconjugated bile acid 3-glucosides, and this can be attributed to the fact that product ions corresponded to amino acid moieties at m/z 74 and 124 are easy to produce under low-energy CID conditions. In addition, both neutral loss scan of 221 Da and precursor ion scan of m/z 202 were useful for extraction of GlcNAc conjugates as shown in Figure 1 (g) and (h). In Figure  1(g) , a neutral loss of 221 Da generated by SNAG-Á 5 -CA, SNAG-Á 5 -CG, and SNAG-Á 5 -CT was found; however, UDCA 7b-GlcNAc and its amino acid conjugates were not present in this chromatogram. Conversely, they were found in the TIC chromatogram on precursor ion scan of m/z 202 as shown in Figure  1 (h) although TUDCA 7b-GlcNAc was not found because of its low intensity. This distinction may be due to presence or absence of a double bond adjacent to 7b-GlcNAc moiety. Table 1 gives m/z values for precursor ions and retention times of all reference standards shown in Figure 1 .
Focused analysis of urine from NPC and 3-HSD deficiency patients
In hepatobiliary disease such as a cholestasis, the output of urinary bile acids increases significantly, and sulphate conjugates are known to constitute the majority of urinary bile acids. Therefore, we analysed urine samples obtained from a healthy volunteer, a healthy infant, a patient with NPC (ingesting UDCA), and a patient with 3b-HSD deficiency using a precursor ion scan of m/z 97. The results are summarized in Table 2 and Supplementary Table 1 . All detected peaks were enumerated in Supplementary  Table 1 , and intense peaks over 10 8 counts were extracted and listed in Table 2 . We found few peaks in TIC chromatograms obtained from urine samples obtained from both a healthy infant and a healthy volunteer. In contrast, the urine samples of an NPC patient and a 3b-HSD deficiency patient contained many peaks corresponding to sulphate conjugates. In addition, there were intense peaks in the NPC sample that differed from those in the urine of the 3b-HSD deficiency patient, suggesting that detection and/or quantitation after developing a quantitative method of their characteristic peaks should permit the two diseases to be distinguished. However, many peaks could not be identified. Next, we performed precursor ion scans of m/z 74 and 124 for extracting glycine and taurine conjugates, respectively; the results also were put into the same tables. Taurine and sulphate double conjugates provided doubly charged deprotonated molecule [M-2H] 2without a singly charged one. Glycine-conjugated and sulphate double conjugates provided both signals with parallel intensity. This information also helped to distinguish sulphated glycine and taurine conjugates. 
